Patents by Inventor Richard B. Love

Richard B. Love has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
    Publication number: 20180071293
    Abstract: Described herein are methods and compositions comprising a covalent TEC family kinase inhibitor for use in adjuvant therapy, including adjuvant cancer therapy, vaccination and treatment of immune disorders and pathogenic infections.
    Type: Application
    Filed: July 14, 2017
    Publication date: March 15, 2018
    Inventors: Joseph J. Buggy, Tarak D. Mody, Richard B. Love, John C. Byrd, Betty Y. Chang, Jason A. Dubovsky, Natarajan Muthusamy, Amy J. Johnson
  • TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
    Publication number: 20140371241
    Abstract: Described herein are methods and compositions comprising a covalent TEC family kinase inhibitor for use in adjuvant therapy, including adjuvant cancer therapy, vaccination and treatment of immune disorders and pathogenic infections.
    Type: Application
    Filed: March 5, 2014
    Publication date: December 18, 2014
    Applicant: Pharmacyclics, Inc.
    Inventors: Joseph J. BUGGY, Tarak D. Mody, Richard B. Love, John C. Byrd, Betty Chang, Jason A. Dubovsky, Natarajan Muthusamy, Amy Jo Johnson
  • TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
    Publication number: 20140134265
    Abstract: Described herein are methods and compositions comprising a covalent TEC family kinase inhibitor for use in adjuvant therapy, including adjuvant cancer therapy, vaccination and treatment of immune disorders and pathogenic infections.
    Type: Application
    Filed: November 1, 2013
    Publication date: May 15, 2014
    Applicant: Pharmacyclics, Inc.
    Inventors: Joseph J. BUGGY, Tarak MODY, Richard B. LOVE, John C. BYRD, Betty CHANG
  • Monoclonal antibodies to type I interferon receptor
    Patent number: 6713609
    Abstract: Anti-IFNAR1 monoclonal antibodies with neutralizing activities against the anti-viral cytopathic effects of various type I interferons are provided.
    Type: Grant
    Filed: April 7, 1998
    Date of Patent: March 30, 2004
    Assignee: Genentech, Inc.
    Inventors: Anan Chuntharapai, Kyung Jin Kim, Richard B. Love, Ji Lu